Ellen Keeley is a Cardiology physician affiliated with University of Florida Health. OpenAlex indexes 161 publications with 11,314 citations (h-index 36); ClinicalTrials.gov lists 1 registered study matched to this name. By OpenAlex citation count, this profile ranks in the top 10% of Interventional Cardiology profiles in the findmyKOL directory.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1600 SW Archer Rd Box 100277
Gainesville, FL 326100001
Telephone
352-273-9065Registry record last updated 21 Jul 2022.
Clinical trials
- Hearts on Fire: Targeting Inflammation in Heart Failure With Preserved Ejection Fraction
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- ABIOMEDProgram year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
88.5%Beta blocker22.8%Carvedilol52%Metoprolol Succinate32%Metoprolol Tartrate16%Part D≥48 patientsStatin17.1%Atorvastatin Calcium82%Rosuvastatin Calcium18%Part D≥65 patients+ 11 more classes in this area
Blood & clotting
9.9%P2Y12 inhibitor7.9%Clopidogrel66%Brilinta18%Prasugrel Hcl16%Part D<11 patientsFactor Xa inhibitor2%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
1.6%SGLT2 inhibitor1.6%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Circulating Biomarkers in Coronary Microvascular Dysfunction
Journal of the American Heart Association
2023 - Microvascular Dysfunction as a Systemic Disease: A Review of the Evidence
The American Journal of Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
John Wingard, MD
University of Florida Health
Barry Byrne, MD
University of Florida Health
Gilbert Upchurch, MD
University of Florida Health
Carmen Allegra, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”